Rankings
▼
Calendar
LNSR Q3 2025 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena
LNSR
LENSAR, Inc.
$142M
Q3 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$14M
+5.7% YoY
Gross Profit
$6M
40.6% margin
Operating Income
-$8M
-52.9% margin
Net Income
-$4M
-25.9% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
+2.7%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$850,000
Balance Sheet
Total Assets
$70M
Total Liabilities
$82M
Stockholders' Equity
-$12M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$14M
+5.7%
Gross Profit
$6M
$6M
-7.3%
Operating Income
-$8M
-$1M
-648.3%
Net Income
-$4M
-$2M
-147.2%
Revenue Segments
Product
$11M
89%
Service
$1M
11%
Geographic Segments
UNITED STATES
$9M
68%
Europe
$2M
18%
Asia Excluding South Korea
$2M
12%
KOREA, REPUBLIC OF
$183,000
1%
Other Geographical Region
$41,000
0%
← Q2 2025
All Quarters